Pomegranate Tirzepatide Review: Availability & Billing Terms
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
A displayed B3 starter offer differs from the marketing headline and carries pharmacy-specific conditions.
Standout details
- Pricing app names the preparation, term and displayed pharmacy
- Default and pharmacy-specific restrictions are stated beside the offer
Things to consider
- Displayed $149 is not a universal price across every dose, pharmacy or term; marketing separately starts at $159
- Default Empower option excludes CA, IA and WI and lists a $60 shipping surcharge for AK, HI and PR
Pomegranate’s pricing app displays $149 per month for tirzepatide plus niacinamide (B3) with the Starter, one-month and Empower options selected. Its separate product page advertises “Starts @ $159/mo.” These public amounts do not establish one price for every preparation or a personal prescription quote; confirm the selected total and any later charge.3,4
Availability comes before a price comparison
The app also offers Advanced and other pharmacy buttons, but the $149 amount belongs to the displayed starter selection. Confirm the prescribed formulation, supplied quantity, complete charge, required labs and renewal authorization. A one-month option is not proof of a particular dose or every later shipment.4,5
The product page says there are no additional fees or membership costs, while the subscription terms describe recurring subscriptions and nonrefundable membership or one-time consultation fees. Ask whether such a fee applies to the chosen order and obtain its amount before payment. The general FAQ says providers may request recent labs or medical records but does not establish that every test is included.3,5,6
The displayed Empower starter option says it is unavailable in California, Iowa and Wisconsin, and lists a $60 shipping surcharge for Alaska, Hawaii and Puerto Rico. Those conditions apply to the displayed option, not necessarily every pharmacy. The app also limits that order to one vial; this does not establish concentration or weekly dosing. Confirm location eligibility and extras beside the product page’s delivery-included language.3,4
Headline and selected availability
| Published detail | What to confirm |
|---|---|
| Public amounts | $149/month starter menu versus $159 starting product headline |
| Displayed preparation | Tirzepatide + B3; Starter / 1 month / Empower |
| Services / fees | Review and delivery advertised; confirm consultation, labs and extras |
| Displayed option limits | Not CA/IA/WI; $60 shipping surcharge AK/HI/PR |
Renewal and medication finality are separate issues
The subscription terms say a plan renews automatically at the selected interval until canceled. For website subscriptions or trials, contact support at least 24 hours before the period ends; the account subscription controls are also described. Deleting an app does not cancel a subscription. Ask for confirmation and the final billing date.5
The same terms say membership and one-time consultation fees are nonrefundable, and medication fees are nonrefundable and nonreturnable. Stopping future renewal does not establish a refund for a paid period or prescription order. The public wording does not settle the charge/refund outcome when no prescription is issued; obtain that rule before paying.5
A separate $25 fee concerns appointments canceled within 24 hours, not a universal medication-cancellation charge. Pharmacy order, delivery or product problems must be reported within 24 hours of delivery; later reports are excluded under the stated policy. Ask what evidence and remedy apply, since a reporting deadline is not an automatic refund promise.5
Contract conditions
| Published detail | What to confirm |
|---|---|
| Future renewal | Contact support at least 24 hours before period end |
| Paid fees / medication | Membership and consultation final; medication nonrefundable/nonreturnable |
| Problem report | Within 24 hours of delivery; confirm evidence and remedy |
| Requested pharmacy | $150 coordination fee; stock/capacity still governs fulfillment |
A requested pharmacy is not a guaranteed assignment
The terms say a requested pharmacy carries a $150 administrative coordination fee, with fulfillment still subject to inventory and capacity. The public menu separately offers Empower, Hallandale, NOVA, OptioRx and Redrock buttons. Ask whether a menu selection triggers that coordination fee and obtain the complete charge. A displayed pharmacy option does not establish the facility assigned to an individual prescription.4,5
The general terms distinguish the technology platform from independent healthcare providers. Confirm the actual treating practice, preparing/dispensing facility, prescription, location eligibility and complete governing agreement. Public quality claims do not independently verify current credentials.7
The product page includes “FDA-licensed manufacturer” marketing language but also says compounded medication has not been FDA reviewed or approved. Compounded tirzepatide is not an FDA-approved finished drug, and that wording is not proof of FDA approval, equivalence or an assigned facility.3,8 Brand-drug trials do not establish outcomes for this platform or a compounded preparation. SURMOUNT-1 and SURMOUNT-5 provide clinical context, not proof that a particular compounded formulation or care program produces the same results.1,2
Further reading
compounded tirzepatide legal status · Zepbound side effects · gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · precision telemed review · compare tirzepatide providers
Frequently asked questions
Is Pomegranate tirzepatide $149 or $159 per month?
The public app shows $149 per month for tirzepatide plus B3 with Starter, one month and Empower selected. The separate product page starts at $159. Confirm the preparation, location eligibility, complete selected charge and renewal; neither amount is a personal prescription quote.
How do I stop automatic renewal?
The subscription terms say to contact support at least 24 hours before the selected period ends and describe account controls. Obtain cancellation confirmation; stopping renewal does not itself refund medication or paid fees.
Can I choose my pharmacy?
The menu offers pharmacy buttons, while the terms describe a $150 coordination fee for a requested pharmacy. Ask whether that fee applies to your selection. Fulfillment still depends on inventory, capacity and the prescription; a displayed name is not an individual assignment.
References(8)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- Pomegranate Health (2026). Compounded Tirzepatide: starting-price page. Pomegranate Health.
- Pomegranate Health (2026). Public pricing app: named preparation and availability. Pomegranate Health.
- Pomegranate Health (2026). Subscription Terms: billing, cancellation and pharmacy coordination. Pomegranate Health.
- Pomegranate Health (2026). General FAQs: review, labs and fulfillment. Pomegranate Health.
- Pomegranate Health (2026). Terms of Service, April 7, 2026. Pomegranate Health.
- FDA (2026). Concerns with unapproved GLP-1 drugs used for weight loss. FDA. Read source
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsPrecision Telemed Tirzepatide Review: Plans and Refunds
Precision Telemed review: $199 intro then $249.99 monthly, prepaid autoship, dose-limited maintenance and the $50 consultation/refund conditions.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
ReadTirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
Read